STAT: Cutting the NIH budget is bad for health and business
Kenneth C. Anderson, president of the American Society of Hematology and a hematologic oncologist at Dana-Farber Cancer Institute

“…Basic scientific research conducted at the NIH and through grants awarded to academic institutions creates the basis for the transformative medicines that industry brings to millions of patients … Compromising this support for the NIH puts at risk our ability to find solutions to the health problems that plague Americans, disrupts an important part of the economy, and impedes a future generation of scientists from entering the field of medical research. … There has never been a time of greater promise for the bench-to-bedside translation of basic advances and making science count for patients with improved capabilities for diagnosis, prognosis, and treatment. And while physicians will keep arguing about the finer points of medicine, the next time they prescribe a new medication that improves the lives of their patients and their families, all will agree that the NIH made it possible” (6/9).